Efforts to conquer antimicrobial resistance are being jeopardized in India due to the sale of huge volumes of antibiotics that combine two anti-microbial drugs in one pill, new analysis from British researchers reveals. Many of these fixed-dose combination (FDC) formulations, as they are known, have not been approved by India’s drug regulator. Their sale is illegal. […]